Vitrolife has secured Japanese regulatory approval for its aspiration needles and micro pipettes, which are used in IVF treatments.
The biotechnology and medical device group develops, manufactures and sells products and systems for the preparation, cultivation and storage of human cells, tissue and organs.
The approval will increase total sales in the Asian market.
Share this article
